HUTCHMED (China) Ltd
LSE:HCM

Watchlist Manager
HUTCHMED (China) Ltd Logo
HUTCHMED (China) Ltd
LSE:HCM
Watchlist
Price: 295 GBX -1.67% Market Closed
Updated: May 29, 2024

HUTCHMED (China) Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HUTCHMED (China) Ltd
Gross Profit Peer Comparison

Comparables:
G
512
U
3933
1177
C
570
C
3320

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
HUTCHMED (China) Ltd
LSE:HCM
Gross Profit
$453.6m
CAGR 3-Years
126%
CAGR 5-Years
45%
CAGR 10-Years
34%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Gross Profit
HK$6.5B
CAGR 3-Years
17%
CAGR 5-Years
16%
CAGR 10-Years
22%
U
United Laboratories International Holdings Ltd
HKEX:3933
Gross Profit
¥6.3B
CAGR 3-Years
19%
CAGR 5-Years
16%
CAGR 10-Years
12%
Sino Biopharmaceutical Ltd
HKEX:1177
Gross Profit
¥21.2B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
13%
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Gross Profit
¥9.3B
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
27%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Gross Profit
HK$38.3B
CAGR 3-Years
6%
CAGR 5-Years
2%
CAGR 10-Years
N/A

See Also

What is HUTCHMED (China) Ltd's Gross Profit?
Gross Profit
453.6m USD

Based on the financial report for Dec 31, 2023, HUTCHMED (China) Ltd's Gross Profit amounts to 453.6m USD.

What is HUTCHMED (China) Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
34%

Over the last year, the Gross Profit growth was 293%. The average annual Gross Profit growth rates for HUTCHMED (China) Ltd have been 126% over the past three years , 45% over the past five years , and 34% over the past ten years .